beta

ACLX

Arcellx Inc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Arcellx Inc. is a clinical-stage biotechnology company. The Company is focused developing controllable cell therapies for the treatment of patients with cancer and other incurable diseases.

Market Cap: 1.64 Billion

Primary Exchange: NASDAQ

Website: https://arcellx.com

Shares Outstanding: 48.4 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 0.6342880616844057

Sector: Professional, Scientific, and Technical Services

Industry: Research and Development in Biotechnology

Ethical Flags

Longest drawdown: 181 trading days

From: 2022-06-10 To: 2022-12-08

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud